Join
Live feed
·
PRReleasevia Quantisnow
Phathom Pharmaceuticals Inc. logo

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAT (Phathom Pharmaceuticals Inc.) and more on Quantisnow.